Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PARP-15 Inhibitors

PARP-15 inhibitors represent a class of chemical compounds designed to target and modulate the activity of the poly(ADP-ribose) polymerase 15 (PARP-15) enzyme. PARP-15 is a member of the PARP family of proteins, which play critical roles in DNA repair mechanisms within cells. These inhibitors are characterized by their ability to interfere with the catalytic function of PARP-15, thereby disrupting specific DNA repair pathways. The primary objective of PARP-15 inhibitors is to hinder the repair of damaged DNA strands in a precise manner.

The mechanism of action underlying PARP-15 inhibitors involves their interaction with the PARP-15 enzyme during DNA damage response. When DNA breaks occur, PARP-15 is one of the first responders at the site of damage. It recognizes DNA strand breaks and facilitates the repair process by adding poly(ADP-ribose) chains to target proteins. This modification recruits other repair proteins to the site. PARP-15 inhibitors disrupt this repair process by binding to the PARP-15 enzyme and blocking the synthesis of poly(ADP-ribose) chains. This interference leads to an accumulation of unrepaired DNA damage in the cell, ultimately resulting in genomic instability and cell death. PARP-15 inhibitors have garnered significant attention in the field of molecular biology and drug discovery due to their applications in cancer, as well as their involvement in DNA damage response pathways, making them valuable tools for studying DNA repair mechanisms and cellular responses to genotoxic stress. Researchers continue to explore the diverse chemical structures and properties of PARP-15 inhibitors, aiming to improve their selectivity and potency in targeting PARP-15 while minimizing off-target effects.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

Olaparib is a PARP inhibitor that competes with NAD+ and traps PARP-15 on DNA, blocking DNA repair, leading to the accumulation of DNA damage and cell death in cancer cells.

Rucaparib

283173-50-2sc-507419
5 mg
$150.00
(0)

Rucaparib inhibits PARP-15 activity, disrupting DNA repair pathways, specifically in BRCA-mutated cancer cells, leading to synthetic lethality.

Talazoparib

1207456-01-6sc-507440
10 mg
$795.00
(0)

Talazoparib binds to PARP-15, blocking DNA repair and causing DNA damage to accumulate, ultimately leading to apoptosis in cancer cells.

Niraparib

1038915-60-4sc-507492
10 mg
$150.00
(0)

Niraparib inhibits PARP-15, blocking DNA repair and causing cancer cell death, particularly in cells with defective homologous recombination repair.

ABT-888

912445-05-7sc-202901
sc-202901A
sc-202901B
1 mg
5 mg
25 mg
$115.00
$170.00
$500.00
24
(1)

Veliparib inhibits PARP-15, disrupting DNA repair and enhancing the cytotoxic effects of DNA-damaging agents in cancer therapy.

4-[4-Fluoro-3-[(4-methoxypiperidin-1-yl)carbonyl]benzyl]phthalazin-1(2H)-one

1174043-16-3sc-497005
5 mg
$430.00
(0)

AZD2461 inhibits PARP-15, impairing DNA repair and causing synthetic lethality in cancer cells, especially those with BRCA mutations.